Han Chong Toh

Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy

Jean-Pierre Abastado, J. Abastado, H. Toh, 2012, Journal of oncology.

MicroRNA‐224 is up‐regulated in hepatocellular carcinoma through epigenetic mechanisms

A. Chung, P. Chow, P. Cole, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Phase III trial of linifanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC).

Wen-Tsung Huang, Masatoshi Kudo, Yoon-Koo Kang, 2013 .

Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model

Johann de Jong, David J Adams, Touati Benoukraf, 2013, Nature Genetics.

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets

Khay Guan Yeoh, Alex Boussioutas, Sandra Bell, 2012, Gut.

Novel proteomic biomarker panel for prediction of aggressive metastatic hepatocellular carcinoma relapse in surgically resectable patients.

Sze Huey Tan, Hwee Tong Tan, H. Toh, 2014, Journal of proteome research.

Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.

Chia Huey Ooi, Sze Huey Tan, Jae Ho Cheong, 2011, Gastroenterology.